Linkers
that enable the site-selective synthesis of chemically
modified proteins are of great interest to the field of chemical biology.
Homogenous bioconjugates often show advantageous pharmacokinetic profiles
and consequently increased efficacy
in vivo
. Cysteine
residues have been exploited as a route to site-selectively modify
proteins, and many successfully approved therapeutics make use of
cysteine directed conjugation reagents. However, commonly used linkers,
including maleimide–thiol conjugates, are not stable to the
low concentrations of thiol present in blood. Furthermore, only a
few cysteine-targeting reagents enable the site-selective attachment
of multiple functionalities: a useful tool in the fields of theranostics
and therapeutic blood half-life extension. Herein, we demonstrate
the application of the pyridazinedione motif to enable site-selective
attachment of three functionalities to a protein bearing a single
cysteine residue. Extending upon previously documented dual modification
work, here we demonstrate that by exploiting a bromide leaving group
as an additional reactive point on the pyridazinedione scaffold, a
thiol or aniline derivative can be added to a protein, post-conjugation.
Thiol cleavability appraisal of the resultant C–S and C–N
linked thio-bioconjugates demonstrated C–S functionalized linkers
to be cleavable and C–N functionalized linkers to be noncleavable
when incubated in an excess of glutathione. The plug-and-play trifunctional
platform was exemplified by attaching clinically relevant motifs:
biotin, fluorescein, a polyethylene glycol chain, and a model peptide.
This platform provides a rare opportunity to combine up to three functionalities
on a protein in a site-selective fashion. Furthermore, by selecting
the use of a thiol or an amine for functionalization, we provide unique
control over linker cleavability toward thiols, allowing this novel
linker to be applied in a range of physiological environments.